Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment

C Ma, S Cui, R Xu - Current Medicinal Chemistry, 2024 - ingentaconnect.com
Background: FMS-like tyrosine kinase 3 (FLT3) is a commonly mutated gene in acute
myeloid leukemia. As a receptor tyrosine kinase (RTK), FLT3 plays a role in the proliferation …
被引用次数：1 相关文章

Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment

C Ma, S Cui, R Xu - Current medicinal chemistry - pubmed.ncbi.nlm.nih.gov
Background FMS-like tyrosine kinase 3 (FLT3) is a commonly mutated gene in acute
myeloid leukemia. As a receptor tyrosine kinase (RTK), FLT3 plays a role in the proliferation …

Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment.

C Ma, S Cui, R Xu - Current Medicinal Chemistry, 2024 - europepmc.org
Background FMS-like tyrosine kinase 3 (FLT3) is a commonly mutated gene in acute
myeloid leukemia. As a receptor tyrosine kinase (RTK), FLT3 plays a role in the proliferation …